Abstract
Background: Nanotechnology exploits materials and devices with a functional organization that has been engineered at the nanometre scale. The application of nanotechnology in neuroscience involves specific interactions with neurons and glial cells. This property is used for delivering drugs and other small molecules (such as genes, oligonucleotides and contrasting agents) across the blood brain barrier (BBB), an important requirement for delivering the drug successfully to the brain.
Objective: Nanotechnology based approaches (NBA) favours transcytosis-mediated delivery of nanoparticles to the brain by crossing the BBB. The last five years have witnessed the successful applications of NBA to treat neurological disorders. It is expected that the development of novel NBA will result in important insights on the brain mechanisms, and eventually provide better medical care to patients suffering from neurological disorders.
Conclusion: This review introduces the emerging work in this area and summarizes the successful NBA used in recent past for treating various neurological disorders ike Alzheimer’s disease, Parkinson's disease, amyotrophic lateral sclerosis, meningitis and glioblastoma.
Keywords: Alzheimer's disease, blood brain barrier, drug delivery, nanotechnology, nanotechnology based approaches, neurological disorders.
Current Drug Metabolism
Title:Frontier View on Nanotechnological Strategies for Neuro-therapy
Volume: 19 Issue: 7
Author(s): Asim Azhar, Ghulam Md. Ashraf*, Qamar Zia, Shakeel A. Ansari, Asma Perveen, Abdul Hafeez, Mohd Saeed, Mohammad A. Kamal, Athanasios Alexiou, Magdah Ganash, Nagendra S. Yarla, Saleh S. Baeesa, Mohamed M. Alfiky and Osama S. Bajouh
Affiliation:
- King Fahd Medical Research Center, King Abdulaziz University, Jeddah,Saudi Arabia
Keywords: Alzheimer's disease, blood brain barrier, drug delivery, nanotechnology, nanotechnology based approaches, neurological disorders.
Abstract: Background: Nanotechnology exploits materials and devices with a functional organization that has been engineered at the nanometre scale. The application of nanotechnology in neuroscience involves specific interactions with neurons and glial cells. This property is used for delivering drugs and other small molecules (such as genes, oligonucleotides and contrasting agents) across the blood brain barrier (BBB), an important requirement for delivering the drug successfully to the brain.
Objective: Nanotechnology based approaches (NBA) favours transcytosis-mediated delivery of nanoparticles to the brain by crossing the BBB. The last five years have witnessed the successful applications of NBA to treat neurological disorders. It is expected that the development of novel NBA will result in important insights on the brain mechanisms, and eventually provide better medical care to patients suffering from neurological disorders.
Conclusion: This review introduces the emerging work in this area and summarizes the successful NBA used in recent past for treating various neurological disorders ike Alzheimer’s disease, Parkinson's disease, amyotrophic lateral sclerosis, meningitis and glioblastoma.
Export Options
About this article
Cite this article as:
Azhar Asim , Ashraf Md. Ghulam *, Zia Qamar , Ansari A. Shakeel, Perveen Asma , Hafeez Abdul , Saeed Mohd , Kamal A. Mohammad , Alexiou Athanasios , Ganash Magdah , Yarla S. Nagendra , Baeesa S. Saleh , Alfiky M. Mohamed and Bajouh S. Osama , Frontier View on Nanotechnological Strategies for Neuro-therapy, Current Drug Metabolism 2018; 19 (7) . https://dx.doi.org/10.2174/1389200219666180305144143
DOI https://dx.doi.org/10.2174/1389200219666180305144143 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
Call for Papers in Thematic Issues
Impact of brain tissue binding and plasma protein binding of drugs in DMPK
The impression of brain tissue binding (BTB) or plasma protein binding (PPB) in Drug Metabolism and Pharmacokinetics is critical to understanding the distribution, efficacy, and potential toxicity of drugs that target the central nervous system (CNS). BTB and high PPB influence the distribution of drugs in the body and their ...read more
Interaction between drugs and endocrine diseases
The introduction of highly active antiretroviral therapy accelerated studies and our understanding on the interaction between pharmacological therapies and endocrine diseases. Drugs can precipitate endocrine via different mechanisms, including direct alteration of hormone production and secretion, dysregulation of hormonal axis, effects on hormonal transport, receptor-binding, and cellular signalling. Common drug-induced ...read more
Metabolism-Mediated Xenobiotic Toxicity
Considering the potent modulation of biotransformation enzyme expression and activities by various therapeutic drugs and environmental chemicals, and the commonly combined exposure of humans to both drugs and the ever increasing environmental pollutants simultaneously, knowledge about the combined toxic effects by modulating biotransformation enzymes, such as P450s, UDP- glucuronosyltransferases, and ...read more
Safety evaluation of vaccine combination
Vaccine combination safety evaluation is a critical field within immunology and public health that focuses on assessing the safety and efficacy of combining different vaccines to maximize protection against various diseases while minimizing potential adverse effects. This process is significant because it ensures that vaccines can be administered together without ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Anti-Inflammatory Adjuvant Agents in Bacterial Meningitis
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Neuropsychiatric Involvement in Systemic Lupus Erythematosus:Current Therapeutic Approach
Current Pharmaceutical Design Applications of 211At and 223Ra in Targeted Alpha-Particle Radiotherapy
Current Radiopharmaceuticals Evaluation of Vancoplus Versus Ceftriaxone Against Cephalosporin Resistance MRSA Strain in Experimental Meningitis Model
Cardiovascular & Hematological Disorders-Drug Targets Severe Hemorrhagic Cystitis Associated with BK Polyoma Virus Infection Following Lung Transplantation
Current Respiratory Medicine Reviews Increased Risk of Falls, Fall-related Injuries and Fractures in People with Type 1 and Type 2 Diabetes - A Nationwide Cohort Study
Current Drug Safety Maternal Sepsis: Current Approaches to Recognition and Clinical Management
Current Women`s Health Reviews The Controversial Role of Adenosine A2A Receptor Antagonists as Neuro-protective Agents
Current Medicinal Chemistry - Central Nervous System Agents Otitis Media: Epidemiology and Management
Infectious Disorders - Drug Targets Aβ Oligomers Induce Glutamate Release from Hippocampal Neurons
Current Alzheimer Research Renin-Angiotensin System in Central Nervous System Diseases and its Interaction with COVID-19
Current Medicinal Chemistry Recent Advances in Lipid-based Nanodrug Delivery Systems in Cancer Therapy
Current Pharmaceutical Design Editorial [Revisiting the Paris Declaration: Pharmacogenomics and Personalized Medicine as Accelerators for Development Aid and Effectiveness]
Current Pharmacogenomics and Personalized Medicine Structure Based Virtual Screening for the Identification of Potential Inhibitors for Penicillin Binding Protein 2B of the Resistant 5204 Strain of <i>Streptococcus pneumoniae</i>
Current Bioinformatics Active Metabolites Resulting from Decarboxylation, Reduction and Ester Hydrolysis of Parent Drugs
Current Drug Metabolism The Mechanism by which the Phenothiazine Thioridazine Contributes to Cure Problematic Drug-Resistant Forms of Pulmonary Tuberculosis: Recent Patents for “New Use”
Recent Patents on Anti-Infective Drug Discovery Ganglioside GM3 and Its Role in Cancer
Current Medicinal Chemistry Dorsal Stream Dysfunction in Children. A Review and an Approach to Diagnosis and Management
Current Pediatric Reviews Crystal Structure of a Putative Methyltransferase SAV1081 from Staphylococcus aureus
Protein & Peptide Letters Oseltamivir in Neonates, Infants and Young Children: A Focus on Clinical Pharmacology
Infectious Disorders - Drug Targets